Profitable Care: Financial Benefits of Medical Management of Caries

Is Medical Management of Caries actually more profitable than routine drill-and-fill restorative dentistry? The data says yes — and most dentists are leaving that money on the table.
Dr. John Frachella is a pediatric dentist with 50 years of experience delivering dental services across public and private settings, including a decade on staff at Oregon Health Sciences University Dental School. He lectures at NYU College of Dentistry for the largest dental residency program in the United States, and he has become one of the most vocal and evidence-driven advocates for Medical Management of Caries (MMC) in clinical practice today. He brings both the science and the business case — and he delivers it with the kind of candor and entertainment value that makes complex clinical content genuinely enjoyable.
In this episode, Dr. Frachella returns to The Dr. Phil Klein Dental Podcast to make the financial argument for MMC — specifically the protocol combining silver diamine fluoride (SDF) and glass ionomer — as a viable, scalable, and highly profitable alternative to conventional restorative treatment. Drawing on randomized clinical trials, CDT coding strategy, and real-world practice examples from across the country, Dr. Frachella dismantles the assumption that MMC is a lower-revenue approach. This episode is a direct follow-up to the previous MMC science and clinical protocol episode — but it stands completely on its own for any clinician ready to look at caries management through a business lens.
Episode Highlights:

Cost-efficiency data comparing SDF alone (80% effective, 5 min, $5) vs. SDF + glass ionomer (96% effective, 20 min, $15) — and why the combination bills as composite per surface under current CDT guidelines
The clinical and financial case for the Silver-Modified Hall technique: 97% effectiveness, no local anesthesia, no preparation, and the same insurance reimbursement as conventional stainless steel crowns
How MMC can be legally delegated to hygienists and dental assistants in many states — dramatically increasing patients treated per provider per day and boosting hourly production
SDF coded as indirect pulp treatment: the clinical rationale supported by RCTs from 2011–2021, and why initiating treatment at the first appointment creates immediate revenue without adding chair time
Real-world MMC practice models demonstrating scalability across public health, private practice, and reservation settings — including patient volumes, acceptance rates, and hygiene-driven production

Perfect for: General dentists and pediatric dentists evaluating the profitability of minimally invasive caries protocols, dental practice owners interested in optimizing chair time and hygiene production, dental residents learning CDT coding strategy, and dental hygienists and assistants working in expanded function or public health settings.
If you've ever assumed MMC was a lower-revenue path, this episode will change your calculus — with the clinical evidence and real practice numbers to back it up.